Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...

Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...

The free lodging, meals, and support Duane received as a guest at Hope Lodge Baltimore made it possible for him to take part ...

An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to new tests ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...

Cancer treatment is undergoing a quiet revolution. Increasingly, what matters most is not where a tumour begins, but what is ...

CSCC is the second most common form of skin cancer, with 1.8 million cases per year in the U.S.¹˒² and 56,000 deaths per year, globally³ ˒ ⁴.Incidence has also increased by 200% over the past three ...

Roche subsidiary, Foundation Medicine, is boosting its presence in the MRD testing space, which it touts as “one of the fastest-growing areas within diagnostics”.

EHR-enabled access has the potential to streamline ordering, accelerate clinical decisions, and drive scalable precision oncology adoption. FORT MYERS, Fla., April 23, 2026--(BUSI ...

Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...

A study identifies blood-based biomarkers that detect colorectal, lung, and ovarian cancers, with performance matching or ...